Biogen is halting the development and commercialization of the Alzheimer's drug Aduhelm, which drew intense scrutiny of its U.S. regulatory process due to.
By Joe Hoppe GSK expects to further grow sales and earnings after its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy helped the.
Medicare patients who were at the highest risk of severe COVID-19 infections were less likely to get Paxlovid or other treatments, according to new research.
The organization will boost its spending to $8.6 billion this year to tackle poverty, healthcare, sustainable agriculture, and other areas where it finds.